US FDA approves first generic version of Plan B
This article was originally published in Scrip
Executive Summary
Watson Pharmaceuticals will be the first company in the US to market a generic version of Teva Pharmaceutical Industries' emergency contraceptive Plan B (levonorgestrel) tablets 0.75mg, after it won approval of its ANDA.